TO: Regulatory Information Service
PR Newswire
RE: Paragraph 3.1.4 of the Disclosure and Transparency Rules
The notification listed below was received under Paragraph 3.1.2 of the
Disclosure and Transparency Rules.
Diageo plc (the "Company") announces that it received notification on 10
November 2011 that Ivan Menezes, a person discharging managerial
responsibilities ("PDMR"), exercised an option on 9 November 2011 over 50,505
American Depositary Shares ("ADS")* granted on 20 September 2005 at a price per
ADS of $59.40 under the Company's Senior Executive Share Option Plan.
Mr Menezes subsequently sold 49,505 ADSs on 9 November 2011, at a price per ADS
of $83.05. Mr Menezes retains the balance of 1,000 ADS.
As a result of the above transaction the interests of Mr Menezes in ordinary
shares of 28 101/108 pence each in the Company ("Ordinary Shares") and ADSs
(excluding options, awards under the Company's LTIPs and interests as a
potential beneficiary of the Company's Employee Benefit Trusts) is 429,280 (of
which 336,281 are held in the form of ADS).
J Nicholls
Deputy Company Secretary
10 November 2011
*1 ADS is the equivalent of 4 Ordinary Shares.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.